The Oxford vaccine has unique advantages, as does Pfizer's. Using both is Australia's best strategy
- Written by Kylie Quinn, Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
On Sunday, federal Chief Medical Officer Professor Paul Kelly said most Australians will be offered a vaccine from Oxford-AstraZeneca.
Australia currently has agreements in place to receive 53.8 million doses of the AstraZeneca shot, and 10 million doses from Pfizer-BioNTech.
So how do these two vaccines compare, how will they be used in Australia,...
Hashtag.net.au
